These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30702021)

  • 21. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
    J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3-year results from the STROLL study.
    Bunte MC; Cohen DJ; Jaff MR; Gray WA; Magnuson EA; Li H; Feiring A; Cioppi M; Hibbard R; Gray B; Khatib Y; Jessup D; Patarca R; Du J; Stoll HP; Massaro J; Safley DM;
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):106-114. PubMed ID: 29521013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
    Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
    J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
    Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.
    Park SH; Rha SW; Choi CU; Kim EJ; Oh DJ; Cho YH; Choi WG; Lee SJ; Kim YH; Choi SH; Kim WH; Kim KC; Cho JH; Kim JH; Kim SM; Bae JH; Bong JM; Kang WY; Baek JY; Seo JB; Chung WY; Park MW; Her SH; Suh J; Kim MW; Kim YJ; Choi HJ; Soh JW;
    Trials; 2014 Sep; 15():355. PubMed ID: 25208688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. French multicenter experience with the GORE TIGRIS Vascular Stent in superficial femoral and popliteal arteries.
    Sibé M; Kaladji A; Boirat C; Cardon A; Chaufour X; Bossavy JP; Saint-Lebes B
    J Vasc Surg; 2017 May; 65(5):1329-1335. PubMed ID: 28222987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: Midterm results.
    Dumantepe M; Seren M; Fazlıogullari O; Ayoglu U; Teymen B
    Vascular; 2021 Oct; 29(5):711-719. PubMed ID: 25687718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
    Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
    J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions.
    Armstrong EJ; Saeed H; Alvandi B; Singh S; Singh GD; Yeo KK; Anderson D; Westin GG; Dawson DL; Pevec WC; Laird JR
    J Endovasc Ther; 2014 Feb; 21(1):34-43. PubMed ID: 24502482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial.
    Laird JR; Zeller T; Loewe C; Chamberlin J; Begg R; Schneider PA; Nanjundappa A; Bunch F; Schultz S; Harlin S; Lansky A; Jaff MR
    J Endovasc Ther; 2018 Feb; 25(1):68-78. PubMed ID: 29285955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vivo Quantification of the Deformations of the Femoropopliteal Segment: Percutaneous Transluminal Angioplasty vs Nitinol Stent Placement.
    Gökgöl C; Schumann S; Diehm N; Zheng G; Büchler P
    J Endovasc Ther; 2017 Feb; 24(1):27-34. PubMed ID: 28095767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.
    Bosiers M; Deloose K; Callaert J; Keirse K; Verbist J; Hendriks J; Lauwers P; D'Archambeau O; Scheinert D; Torsello G; Peeters P
    J Endovasc Ther; 2013 Dec; 20(6):746-56. PubMed ID: 24325689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease.
    Fujihara M; Takahara M; Sasaki S; Nanto K; Utsunomiya M; Iida O; Yokoi Y
    J Endovasc Ther; 2017 Jun; 24(3):367-375. PubMed ID: 28351208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.